Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, November 14, 2015 11:46:03 AM
bullish 2.85
high volume green
## source: finance.yahoo.com
Thu, 12 Nov 2015 13:38:08 GMT ~ VBI VACCINES INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/151112/vbiv8-k.html
*********************************************************
Fri, 06 Nov 2015 13:54:10 GMT ~ VBI Vaccines to Present Update and New Data Supporting its RSV and CMV Vaccine Programs at the World Vaccine Congress Europe
[at noodls] - CAMBRIDGE, Mass. and VANCOUVER, British Columbia, Oct. 30, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) ('VBI') and SciVac Therapeutics Inc. (TSX:VAC) (OTCQX:SVACF) ('SciVac') will host a joint ...
read full: http://www.noodls.com/view/5B31E94744B8654D0D9360B639EBE2AC56A7BA6D
*********************************************************
Fri, 06 Nov 2015 13:31:50 GMT ~ VBI VACCINES INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/151106/vbiv8-k.html
*********************************************************
Fri, 06 Nov 2015 13:30:00 GMT ~ VBI Vaccines to Present Update and New Data Supporting its RSV and CMV Vaccine Programs at the World Vaccine Congress Europe
[GlobeNewswire] - CAMBRIDGE, Mass. -- VBI Vaccines Inc. ("VBI") is scheduled to present at the 16th Annual World Vaccine Congress Europe on Tuesday, November 10th, 2015 at 6:30 AM ET (12:30 PM CET). The event ...
read full: http://finance.yahoo.com/news/vbi-vaccines-present-data-supporting-133000061.html
*********************************************************
Thu, 05 Nov 2015 13:36:21 GMT ~ VBI VACCINES INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/151105/vbiv8-k.html
*********************************************************
$VBIV charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$VBIV company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/VBIV/company-info
Ticker: $VBIV
OTC Market Place: Not Available
CIK code: 0000704159
Company name: VBI Vaccines Inc.
Company website: http://www.paulsoninvestment.com
Incorporated In: DE, USA
$VBIV share structure
## source: otcmarkets.com
Market Value: $57,086,241 a/o Nov 13, 2015
Shares Outstanding: 20,030,260 a/o Jul 31, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$VBIV extra dd links
Company name: VBI Vaccines Inc.
Company website: http://www.paulsoninvestment.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=VBIV+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=VBIV+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=VBIV+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/VBIV/news - http://finance.yahoo.com/q/h?s=VBIV+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/VBIV/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/VBIV/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=VBIV+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/VBIV
DTCC (dtcc.com): http://search2.dtcc.com/?q=VBI+Vaccines+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=VBI+Vaccines+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=VBI+Vaccines+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.paulsoninvestment.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.paulsoninvestment.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.paulsoninvestment.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/VBIV
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000704159&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/VBIV/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/VBIV/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=VBIV&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=VBIV
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/VBIV/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=VBIV+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=VBIV+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=VBIV
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=VBIV
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=VBIV+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/VBIV/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=VBIV+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/VBIV.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=VBIV
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/VBIV/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/VBIV/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/VBIV
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/VBIV
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/VBIV:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=VBIV
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=VBIV
$VBIV DD Notes ~ http://www.ddnotesmaker.com/VBIV
Recent VBIV News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:05:34 PM
- VBI Vaccines Provides an Update on its Restructuring Proceedings • Business Wire • 08/02/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 02:28:18 PM
- VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives • Business Wire • 07/30/2024 01:55:00 PM
- VBI Vaccines Announces Results of Annual General Meeting • Business Wire • 06/25/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 12:00:20 PM
- VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients • Business Wire • 05/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 09:00:33 PM
- VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients • Business Wire • 05/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:18:29 PM
- VBI Vaccines Reports First Quarter 2024 Financial Results • Business Wire • 05/15/2024 08:00:00 PM
- VBI Vaccines Reports Full Year 2023 Financial Results • Business Wire • 04/16/2024 12:00:00 PM
- VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • Business Wire • 04/11/2024 08:05:00 PM
- VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • Business Wire • 04/09/2024 06:45:00 PM
- VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma • Business Wire • 04/03/2024 12:00:00 PM
- VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform • Business Wire • 04/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 01:34:40 PM
- VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences • Business Wire • 02/14/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:23:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:15:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:15:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 01:00:27 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM